Amanote Research

Amanote Research

    RegisterSign In

CRISPR/Cas9 and P53: An Odd Couple Requiring Relationship Management

Molecular Therapy - United States
doi 10.1016/j.ymthe.2018.11.001
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
Date

December 1, 2018

Authors
Seppo Ylä-Herttuala
Publisher

Elsevier BV


Related search

CRISPR/Cas9: Prospects and Challenges

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2015English

What Is CRISPR/Cas9?

Archives of Disease in Childhood: Education and Practice Edition
Child HealthPediatricsPerinatology
2016English

An Allosteric Signaling Governs the CRISPR-Cas9 Function

Biophysical Journal
Biophysics
2019English

CRISPR-Cas9 Technology, Safety and Evaluation From an Ethical Perspective

Journal of Literature Pharmacy Sciences
2020English

CRISPR-Cas12 and Cas13: The Lesser Known Siblings of CRISPR-Cas9

Cell Biology and Toxicology
MutagenesisToxicologyHealthCell Biology
2019English

CRISPR/Cas9 Technology in Translational Biomedicine

Cellular Physiology and Biochemistry
Physiology
2020English

Improving CRISPR-Cas9 On-Target Specificity

2017English

CRISPR/Cas9-mediated Targeted Mutagenesis in Grape

PLoS ONE
Multidisciplinary
2017English

CRISPR/Cas9: A Tool for Immunological Research

European Journal of Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy